Given that the fight between compounding pharmacies, the FDA, and commercial entities manufacturing GLP1s has generally played out, however it seems like Later on there is not going to even be considered a struggle above Retatrutide:An evaluation with the literature was performed to examine the likely influence from the emerging drug retatrutide on